TD Asset Management’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-472
| Closed | -$220K | – | 1430 |
|
|
2023
Q1 | $220K | Sell |
472
-996
| -68% | -$527K | ﹤0.01% | 1372 |
|
|
2022
Q4 | $588K | Buy |
+1,468
| New | +$562K | ﹤0.01% | 1254 |
|
|
2021
Q2 | – | Sell |
-2,269
| Closed | -$1.97M | – | 1538 |
|
|
2021
Q1 | $1.97M | Sell |
2,269
-1,024
| -31% | -$1.09M | ﹤0.01% | 1112 |
|
|
2020
Q4 | $3.05M | Sell |
3,293
-200
| -6% | -$210K | ﹤0.01% | 910 |
|
|
2020
Q3 | $3.59M | Buy |
3,493
+420
| +14% | +$452K | 0.01% | 792 |
|
|
2020
Q2 | $3.11M | Buy |
3,073
+1,456
| +90% | +$1.35M | ﹤0.01% | 770 |
|
|
2020
Q1 | $1.41M | Sell |
1,617
-352
| -18% | -$350K | ﹤0.01% | 910 |
|
|
2019
Q4 | $2.11M | Sell |
1,969
-92
| -4% | -$93.9K | ﹤0.01% | 914 |
|
|
2019
Q3 | $1.91M | Hold |
2,061
| – | – | ﹤0.01% | 917 |
|
|
2019
Q2 | $2.33M | Sell |
2,061
-32
| -2% | -$35K | ﹤0.01% | 883 |
|
|
2019
Q1 | $2.84M | Buy |
2,093
+236
| +13% | +$320K | ﹤0.01% | 830 |
|
|
2018
Q4 | $2.15M | Sell |
1,857
-24
| -1% | -$27K | ﹤0.01% | 899 |
|
|
2018
Q3 | $2.86M | Buy |
1,881
+24
| +1% | +$37K | ﹤0.01% | 899 |
|
|
2018
Q2 | $2.91M | Buy |
1,857
+312
| +20% | +$407K | ﹤0.01% | 854 |
|
|
2018
Q1 | $1.78M | Buy |
1,545
+228
| +17% | +$300K | ﹤0.01% | 908 |
|
|
2017
Q4 | $1.56M | Buy |
1,317
+40
| +3% | +$50.2K | ﹤0.01% | 944 |
|
|
2017
Q3 | $1.72M | Buy |
1,277
+245
| +24% | +$258K | ﹤0.01% | 911 |
|
|
2017
Q2 | $833K | Sell |
1,032
-40
| -4% | -$27.9K | ﹤0.01% | 1088 |
|
|
2017
Q1 | $661K | Sell |
1,072
-68
| -6% | -$41.4K | ﹤0.01% | 1144 |
|
|
2016
Q4 | $610K | Buy |
1,140
+12
| +1% | +$5.99K | ﹤0.01% | 1138 |
|
|
2016
Q3 | $584K | Sell |
1,128
-12
| -1% | -$5.65K | ﹤0.01% | 1141 |
|
|
2016
Q2 | $468K | Sell |
1,140
-12
| -1% | -$5.5K | ﹤0.01% | 1133 |
|
|
2016
Q1 | $613K | Sell |
1,152
-56
| -5% | -$27.9K | ﹤0.01% | 1060 |
|
|
2015
Q4 | $920K | Sell |
1,208
-32
| -3% | -$21.2K | ﹤0.01% | 970 |
|
|
2015
Q3 | $680K | Buy |
1,240
+60
| +5% | +$36.3K | ﹤0.01% | 1011 |
|
|
2015
Q2 | $693K | Buy |
1,180
+52
| +5% | +$30.2K | ﹤0.01% | 1047 |
|
|
2015
Q1 | $885K | Buy |
1,128
+96
| +9% | +$74.4K | ﹤0.01% | 974 |
|
|
2014
Q4 | $705K | Buy |
+1,032
| New | +$664K | ﹤0.01% | 1012 |
|
Other funds holding KYNB
AC
TD Asset Management's KYNB Position: Q2 2023 in Review
TD Asset Management sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 472 shares — an estimated $220K sold.
TD Asset Management first reported a position in KYNB in Q4 2014 and held it in 28 quarters. The position peaked at $3.59M in Q3 2020. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.
- TD Asset Management reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
- TD Asset Management sold 472 Kyntra Bio shares in Q2 2023, an estimated $220K.
- TD Asset Management first reported a position in Kyntra Bio in Q4 2014 and held it in 28 quarters.
- TD Asset Management's Kyntra Bio position peaked at $3.59M in Q3 2020.
- 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.
Based on TD Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.